Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
about
Corticosteroids for the long-term treatment in multiple sclerosisGenes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.Expression of scavenger receptor A on antigen presenting cells is important for CD4+ T-cells proliferation in EAE mouse model.Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.Multiple sclerosis therapeutic pipeline: opportunities and challenges.Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis
P2860
Q24242150-7ABA5DBB-3FD7-4B98-80F6-43B699052036Q33325679-6D94D748-3065-4638-82EF-3AEC9D959AEFQ34409308-85B480B6-377C-492F-BA03-872690E7A2CBQ34499810-457BA24A-D35B-4831-90EB-F4F6CC93F379Q36303893-439BCFB3-B8D1-41BE-9ED2-49B19E991C8FQ36963171-C233B77B-0E3F-4E1F-B058-B4D6C55A0D5BQ37855722-98D95BED-CB92-44C6-99AF-88F92B9AE79AQ41173582-0ADE5B5A-71E2-49FE-B814-DEC764EB2EC6Q57911818-E363A26B-C5D7-4CC3-BDE1-74A4F3A8019E
P2860
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Therapeutic considerations for ...... ence, and future expectations.
@ast
Therapeutic considerations for ...... ence, and future expectations.
@en
type
label
Therapeutic considerations for ...... ence, and future expectations.
@ast
Therapeutic considerations for ...... ence, and future expectations.
@en
prefLabel
Therapeutic considerations for ...... ence, and future expectations.
@ast
Therapeutic considerations for ...... ence, and future expectations.
@en
P2093
P50
P1433
P1476
Therapeutic considerations for ...... ence, and future expectations.
@en
P2093
Anat Achiron
Brian Weinshenker
Bruce A C Cree
Elliot M Frohman
J Theodore Phillips
John Corboy
Kathleen Hawker
Lawrence Steinman
Michael K Racke
Scott Zamvil
P304
P356
10.1001/ARCHNEUR.62.10.1519
P50
P577
2005-10-01T00:00:00Z